The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

The best metric is not weight, but a particularly toxic kind of fat.

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

Two patients with MASH share their paths to diagnosis, including the challenges they faced and what it took to find answers.

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...